Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_232_библиотеки_им_акад_М_И_Перельмана
.pdf
13. Com
p
lications of Assisted Re
p
roduction 13
3
b
etween ovarian stimu
l
ation an
d
cancer ris
k
s. W
h
i
l
e current stu
d
ies on t
h
e
s
a
f
et
y
o
f
assiste
d
repro
d
uction are
g
enera
lly
reassurin
g
, t
h
e stu
dy
by
Hansen
et a
l
. [23] reportin
g
a
h
i
gh
er ris
k
o
f
b
irt
h
d
e
f
ects is o
f
concern. Internationa
l
co
ll
a
b
oration is nee
d
e
d
to a
dd
ress t
h
is uncertainty.
e
f
erences
1. Sc
h
en
k
er JG. Prevention an
d
treatment o
f
ovarian
hy
perstimu
l
ation s
y
n
d
rome.
H
um
R
e
p
ro
d
. 1993;8:653–659.
2. Go
l
an A, Ron-e
l
R, Herman A, So
ff
er Y, Weinrau
b
Z, Caspi E. Ovarian
h
yperstimu
l
a-
t
ion syn
d
rome. O
b
ste
t
G
y
neco
l
S
urv.
1989;
44:4
30
–44
0
.
3. Delvigine A, Rozenberg S. Review of the clinical course and treatment of ovarian
h
yperstimulation syndrome.
H
u
m
R
epro
d
Update
.
2003
;
9:77–9
6.
4. Mashiach S, Bider D, Morano O, Goldenber
g
M, Ben-Rafael Z. Adnexal torsion of
hy
perstimulated ovaries in pre
g
nancies after
g
onadotropin therap
y
. F
ert
Steril.
990;73:901–907
.
5. D’An
g
elo A, Amso N. Coastin
g
for preventin
g
ovarian h
y
perstimulation s
y
ndrome.
oc
h
ran
e
Data
b
ase
Sy
s
t
R
ev
.
2002;3:CD002811
.
6. D’An
g
e
l
o A, Amso N. Em
b
r
y
o
f
reezin
g
f
or preventin
g
ovarian
hy
perstimu
l
ation
s
y
n
d
rome.
oc
h
ran
e
Data
b
ase
Sy
s
t
R
ev
.
2002;2:CD002806
.
7. A
b
ou
l
g
h
ar M, Evers JH, A
l
-Inany H. Intra-venous a
lb
umin
f
or preventing severe
o
varian
h
yperstimu
l
ation syn
d
rome. Coc
h
ran
e
D
ata
b
as
e
Sy
st
R
ev
.
2002;2
:
C
D001302
.
8. Olivennes F, Kadhel P, Rufat P, Fanchin R, Fernandez H, Frydman R. Perinatal
o
utcome of twin pre
g
nancies obtained after in vitro fertilization: a comparison with
twin pre
g
nancies obtained spontaneousl
y
or after ovarian stimulation. F
ert
Steril.
996;66:105–109
.
9. Gerris J, De Neubour
g
D, Man
g
elschots K, Van Ro
y
en E, Van de Meerssche M,
V
a
lk
en
b
ur
g
M. Prevention o
f
twin pre
g
nanc
y
a
f
ter in-vitro
f
erti
l
ization or intrac
y
s-
top
l
asmic sperm in
j
ection
b
ase
d
on strict em
b
r
y
o criteria: a prospective ran
d
omise
d
cl
inica
l
tria
l
.
H
u
m
Re
p
ro
d.
1999
;
1
4:
2
5
81
–
2
5
8
7.
10. Mart
k
ainen H, Tiitinen A, Tomas C, Tapanainen J, Orava M, Finnis
h
ET stu
d
y
group. One versus two em
b
ryo trans
f
er a
f
ter IVF an
d
ICSI: a ran
d
omise
d
stu
d
y.
Hum
R
eprod
.
2001
;
1
6
:1900–1903
.
11. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk:
c
ollaborative anal
y
sis of 12 US case-control studies. Invasive epithelial ovarian
c
ancers in white women. Collaborative Ovarian Cancer Grou
p
.
Am
J
E
p
idemiol.
992;136:1184–1203.
2. Rossin
g
MA, Da
l
in
g
JR, Weiss NS, Moore DE, Se
lf
SG. Ovarian tumours in a co
h
ort
o
f
in
f
erti
l
e women.
N
En
gl
J
Me
d.
1994;331:771–776.
13. Venn A, Watson L, Bruinsma F, Gi
l
es G, Hea
ly
D. Ris
k
o
f
cancer a
f
ter use o
f
f
erti
l
it
y
d
rugs wit
h
in-vitro
f
erti
l
ization.
L
ancet
.
1994
;
354:158
6
–1590.
https://t.me/med1917
34 K.J. On
g
et al.
14. Klip H, Bur
g
er CW, Kenemans P, Van Leeuwen FE. Cancer risk associated with
su
bf
erti
l
it
y
an
d
ovu
l
ation in
d
uction: a review.
ance
r
auses
ontro
l
.
2000
;
11
:
319
–
3
44.
15. Lu
d
wig AK, G
l
awatz M, Griesinger G, Die
d
ric
h
K, Lu
d
wig M. Perioperative an
d
p
ost-operative comp
l
ications o
f
transvagina
l
u
l
trasoun
d
-gui
d
e
d
oocyte retrieva
l
:
p
rospective stu
d
y o
f
1000 oocyte retrieva
l
s.
H
u
m
R
epro
d
. 200
6;
21:3235–3240
.
16. Bennett SJ, Waterstone JJ, Cheng WC, Parsons J. Complications of transvaginal
u
ltrasound-directed follicle as
p
iration: a review of 2760 consecutive
p
rocedures.
J
Assist
Re
p
ro
d
enet. 1993;10:772–778.
17. Govaerts I, Devreker F, Delbaere A, Revelard P, En
g
lert Y. Short-term medical
c
omplications of 1500 ooc
y
te retrieval for in vitro fertilization and embr
y
o transfer.
Eur
J
bstet G
y
neco
l
Re
p
ro
d
B
iol.
1998;77:239–243.
8. E
l
-S
h
awar
by
SA, Mar
g
ara RA, Trew GH, La
ff
an MA, Laver
y
SA. A review o
f
comp
l
ications
f
o
ll
owin
g
transva
g
ina
l
ooc
y
te retrieva
l
f
or in vitro
f
erti
l
ization.
H
um
F
erti
l.
200
4
;
7:
12
7–
133.
19. Dic
k
er D, As
hk
enazi J, Fe
ldb
erg D, Levy T, De
k
e
l
A, Ben Ra
f
ae
l
Z. Severe a
bd
omina
l
comp
l
ication a
f
ter transvagina
l
u
l
trasonograp
h
ica
ll
y gui
d
e
d
retrieva
l
o
f
oocytes
f
or
in vitro fertilization and embryo transfer.
Fert
Steril
.
1993
;
59:1313–1315
.
2
0. Schlegel PN, Palermo GD, Goldstein M, et al. Testicular sperm extraction with
intrac
y
toplasmic sperm in
j
ection for nonobstructive azoospermia.
rolog
y
. 1997;49:
4
35
–44
0.
2
1. Nazari A, As
k
ari HA, C
h
ec
k
JH, O’S
h
au
gh
ness
y
AC. Em
b
r
y
o trans
f
er tec
h
nique as
a cause o
f
ectopic pre
g
nanc
y
in in vitro
f
erti
l
ization.
F
ert
S
teri
l.
1993;60:919.
2
2. Bennett SJ, Waterstone JJ, C
h
eng WC, Parsons J. Comp
l
ications o
f
transvagina
l
ul
trasoun
d
d
irecte
d
f
o
ll
ic
l
e aspiration: a review o
f
2670 consecutive proce
d
ures.
J
A
ssist Repro
d
enet.
1993;10
:7
2
.
2
3. Hansen M, Bower C, Milne E, de Klerk N, Kurinczuk JJ. Assisted re
p
roductive tech
-
nologies and the risk of birth defects—a systemic review.
H
u
m
Reprod
.
200
5
;20
:
3
2
8
–
338.
24. Bounduelle M, Van Assche E, Joris H, Ke
y
molen K, Devroe
y
P, Van Steirte
g
hem A.
Prenatal testin
g
in ICSI pre
g
nancies: incidence of chromosome anomalies in 1586
k
ar
y
ot
y
pes and relation to sperm parameters.
Hum
Re
p
rod. 2002;17:2600–2614.
25. Bon
d
ue
ll
e M, Wenner
h
o
l
m UB, Lo
f
t A. A mu
l
ti centre co
h
ort stu
dy
o
f
p
hy
sica
l
h
ea
l
t
h
o
f
5
y
ear o
ld
c
h
i
ld
ren conceive
d
a
f
ter intrac
y
stop
l
asmic sperm in
j
ection, in
vitro
f
erti
l
ization an
d
natura
l
conception.
H
u
m
Repro
d
.
200
5
;20
:4
13
–4
19
.
26. Lan
d
JA, Evers JL. Ris
k
s an
d
comp
l
ications in assiste
d
repro
d
uction tec
h
niques:
report o
f
an ESHRE consensus meeting.
H
um
R
epro
d.
2003;18
:455–457
.
https://t.me/med1917
In
d
ex
A
bd
omina
l
wa
ll
laparoscopic sur
g
er
y
and perforation of,
29
t
rocar
,
hernia at site of
,
25
Abdominal wound closure
,
43–49
f
ai
l
ure o
f
, 43–44
m
anagement o
f
, 48–4
9
m
ana
g
ement o
f
l
ate, 49
f
ascia c
l
osure an
d
, 46–4
7
superfi
cial
,
47
hernia
,
incisional and
,
44–45
i
ncisions for
,
4
5
peritoneum closure and, 45–4
6
r
isk factors, 44–4
5
s
kin closure and, 4
8
superfi
cia
l
b
rea
kd
own o
f
, 49
s
urgica
l
consi
d
erations
f
or, 4
5
ACC/AHA. Se
e
American Co
ll
e
g
e o
f
C
ar
d
io
l
o
gy
/American Heart
Association
Ade
p
t, adhesion
p
revention with, 57–59,
58f
Adhesiolysis, 34
Adhesion
(
s
)
f
ormation, 52, 10
3
hy
steroscopic sur
g
er
y
an
d
f
ormation o
f
,
1
03
i
ntraa
bd
omina
l
, past sur
g
ica
l
h
istor
y
an
d
,
6
8
,
69
t
Adhesion
p
revention
A
de
p
t for, 57–59, 58f
adjuvants, 5
2
crystalloid for, 52–5
3
Interceed for, 58–59, 58
f
Interge
l
f
or, 53–59, 58
f
r
ecent a
d
vances in, 52–59
AFS.
S
ee American Ferti
l
it
y
Societ
y
A
lb
umin, 12
9
American Colle
g
e of Cardiolo
gy
/American
H
eart Association (ACC/AHA), 87,
8
7t
American Fertility Society (AFS), 5
4
American Society of Anesthesiologists
cat
i
on, 86, 86
t
Anaero
b
ic t
h
res
h
o
ld
(AT), 8
8
Anastomotic
l
ea
k
, 15
Anesthesia
complications related to, laparoscop
y
a
nd
,
25–2
6
high-risk patient and intraoperative, 91
laparoscopy, complications related to,
25
–2
6
r
a
d
ica
l
sur
g
er
y
comp
l
ications an
d
,
2–1
3
r
is
k
re
d
uction re
l
atin
g
to, 12–1
3
Anti
b
iotic
s
i
nfection followin
g
gy
necolo
g
ical sur
g
er
y
a
nd choice of
,
5
,
6
t
prophylactic, 8
h
ysterectomy, 9
T
OP, 8–
9
ASA classifi
catio
n
.
S
ee American Society o
f
Anesthesiologists classifi
catio
n
Assiste
d
re
p
ro
d
uction
com
p
lications, 127–13
3
o
varian stimulation and
,
127–13
0
embryo transfer technique complications
a
nd
,
131–13
2
s
afety, 132
s
urgical procedures, complications
a
ssociate
d
wit
h
, 130–131
AT
.
Se
e
An
ae
r
ob
i
c
th
r
eshold
B
Bacterial va
g
inosis (BV), 3
antibiotics for
,
5
i
nfectious morbidit
y
, post-h
y
sterectom
y
a
nd
,
4–
5
vaginal cuff cellulitis, post-hysterectom
y
a
n
d
, 4–
5
Benzy
l
penici
ll
in, 13
Bipo
l
ar e
l
ectrosur
g
ica
l
d
evice, 97–9
8
B
l
a
dd
er in
j
uries, 7
5
t
reatment
,
81
Blunt-ti
p
trocars, 2
7
Bowel in
j
uries, laparoscopic sur
g
er
y
, 21–22,
6
8–
6
9
,
6
8t
,
7
1
access methods and
,
23–2
4
BV
.
S
e
e
Bacterial vaginosis
https://t.me/med1917
In
d
e
x
C
C
ancer.
S
ee Ra
d
ica
l
cancer surgery;
specifi
c
cancers
Car
d
iopu
l
monar
y
exercise (CPX) testin
g
,
88
Car
d
iovascu
l
ar ris
k
ACC/AHA
g
uidelines for, 87, 87t
gy
necolo
gy
patient and, 86–87
C
DL
C
.
S
e
e
Continuous double-loop closur
e
Cefazolin
,
5
Cep
h
a
l
osporins, 1
3
Cervica
l
cancer, surgery, 11, 1
4
Cervica
l
d
i
l
ation,
hy
steroscop
y
, 9
9
Cervica
l
intrae
p
it
h
e
l
ia
l
neo
pl
asia (CIN), 15
Cesarean section, Pomero
y
method of
sterilization at
,
117
Cholecystectomy, laparoscopic, 2
1
C
IN.
S
e
e
Cervical intraepithelial neoplasi
a
Clomiphene, 129
Commun
i
cat
i
on, 63
Continuous
d
ou
bl
e-
l
oop c
l
osure (CDLC), 4
7
Contraception, steri
l
ization an
d
p
re
p
roce
d
ure, 116. See a
l
s
o
Ora
l
contrace
p
tive
p
i
ll
Counselin
g
e
ndometriosis
p
reo
p
erative, 36
h
ysteroscopic preoperative, 9
6
CPX test
i
ng.
S
e
e
Cardiopulmonary exercise
t
est
i
ng
Cryopreservat
i
on, 127
Crysta
ll
oi
d
, a
dh
esion prevention, 52–5
3
C
y
stoscop
y
, 79
D
D
extran
,
100
Dextrose
,
10
0
Dissection, urinar
y
tract in
j
ur
y
prevention
a
nd
,
76–77
Distension media, hysteroscopy, 99–10
2
D
ocu
m
e
n
tation
a
d
verse event, 65
hy
steroscopic sur
g
er
y
, 9
6
urinar
y
tract in
j
ur
y
, 8
2
Dox
y
c
y
cline, 7
E
E
ctopic pregnancy, 110–11
1
E
lective single embryo transfer (eSET), 12
9
E
lectrocautery coagulation, 10
6
E
lectrosurgery, 9
7
b
ipo
l
ar
d
evice
f
or, 97–9
8
E
m
b
ryo trans
f
er tec
h
nique, comp
l
ications
a
ssociate
d
wit
h
, 131–132
E
ndometrial cance
r
l
ymphadenectomy in, 1
7
s
urgery, 1
1
E
n
do
m
et
ri
os
i
s
l
aparoscopic surgery
f
or
a
u
d
it
f
or, 3
8
a
u
d
it resu
l
ts
f
or
,
38–41
,
39
f,
39t
,
41
t
c
om
p
lications of, 34–4
1
dissection for
,
36–37
,
37f
innovation in
,
41
p
atient counseling for, 3
6
rectal involvement/resection and
,
4
0
surgica
l
ris
k
s o
f
, 40, 41
b
surgica
l
tec
h
niques, 36–38
team a
pp
roac
h
to, 37–3
8
n
o
d
u
l
ar, 35, 35
f
s
ur
g
er
y
,
3
4–4
1
c
om
p
lications, 34
m
ana
g
ement,
3
4–
35
s
ymptoms,
34
E
ndoTIP system, laparoscopic surgery, 2
7
E
nterostom
i
es, 3
4
E
ryt
h
ropoietin, 1
4
eSET.
S
e
e
E
l
ective sing
l
e em
b
ryo trans
f
er
Extraperitoneal insuffl
ation,
p
neumo
p
eritoneum an
d
, 2
5
F
F
ascia closure
,
46–4
7
F
ebrile morbidity, hysterectomy and, 3–4
F
ertility, 15.
S
ee als
o
American Fertility
Society; Assisted reproduction
F
ie
ldl
er puncture nee
dl
e,
l
aparoscopic
surgery, 20
F
i
l
s
h
ie c
l
i
p
steri
l
ization, 108, 109t, 117
c
l
ip mi
g
ration, 121
d
ropped “lost” clips and, 12
1
failure of, 108, 109t
operative technique for, 118–120, 118f
operator error an
d
, 112
F
istu
l
a, ra
d
ica
l
gyneco
l
ogica
l
surgery, 1
4
F
istu
l
o
g
ram, 80–8
1
G
Gas embolism,
p
neumo
p
eritoneum and, 25
G
D
T
.
S
e
e
Goal-directed therap
y
Gentam
i
c
i
n, 13
Glycine, 9
7
d
istension me
d
ia, 100
Goa
l
-
d
irecte
d
t
h
erap
y
(GDT), 9
0
G
y
neco
l
o
g
ica
l
cancer
comor
b
i
d
it
y
, 1
2
laparoscopic sur
g
er
y
, 17
https://t.me/med1917
In
d
ex 1
37
s
urgery
r
e
d
ucing comp
l
ications o
f
, 1
6
surgeon an
d
, 17
th
rom
b
osis ris
k
an
d
, 13
G
y
neco
l
o
g
ica
l
onco
l
o
gy
, comp
l
ications in,
–
18
G
y
necolo
g
ical sur
g
er
y
.
S
ee also Hi
g
h-risk
gy
necolo
gy
patient
i
nfection following
a
ntibiotics for
,
choice of
,
5
,
6t
p
at
h
ogenesis o
f
, 1–3
p
revention o
f
, 1–9
i
ntrao
p
erative a
d
verse events an
d
bl
ame an
d
, 65
documentation of
,
62
incident reportin
g
of, 64
root cause analysis for, 64–6
5
p
atient communication and, 6
3
p
ost-operat
i
on, 61–6
6
p
ostoperat
i
ve management, 63
p
reoperat
i
ve care, 6
2
r
e
l
atives, communicating wit
h
an
d
, 63
risk assessment specifi
c to, 88–89, 89t
t
eam, 63–6
4
u
reteric in
j
ur
y
, 7
5
u
rinar
y
tract in
j
ur
y
, 75–8
2
H
Hasson-style laparoscopy access, 2
6
bowel injuries and, 23–2
4
h
ematoma an
d
, 24–2
5
morta
l
it
y
, 2
3
s
a
f
et
y
, 23
u
rinar
y
in
j
uries an
d
, 24
v
ascu
l
ar in
j
uries an
d
, 2
4
w
ound infection
,
25
h
CG
.
S
ee Human chorionic
g
onadotropins
Hematoma, laparoscopic surgery, 24–25
Hemorrhage
h
ysteroscopic surgery, 102–10
3
r
a
d
ica
l
cancer surgery comp
l
ications an
d
,
He
p
arin.
S
e
e
Low-mo
l
ecu
l
ar-wei
gh
t
h
epari
n
Hernia
abdominal wall trocar
,
2
5
i
ncisional
,
abdominal wound closure and
,
44
–
45
High-risk gynecology patien
t
assessment of, 84–9
2
a
pproac
h
to, 85–89
cl
inica
l
mar
k
ers
f
or, 86–87
f
unctiona
l
capacit
y
an
d
, 87–8
8
surgery-specifi
c ris
k
an
d,
88–89
,
89
t
cardiovascular risk and
,
86–8
7
i
dentifying, 92
management o
f
i
ntraoperat
i
ve, 90–9
1
my
ocar
d
ia
l
isc
h
emia an
d
, 89–9
0
o
x
yg
en
d
e
l
iver
y
, optimizin
g
an
d
, 90
p
osto
p
erative, 9
1
p
reo
p
erative, 89–91
p
atient characteristics and outcome for,
8
4
p
hysiological stress and, 84, 85t
H
ormone replacement therapy (HRT), 1
3
H
RT
.
S
ee Hormone rep
l
acement t
h
erap
y
H
uman c
h
orionic gona
d
otropins (
h
CG),
2
8
Hy
sterectom
y
abdominal
,
3–4
v
a
g
inal
v.
,
4
antibiotics, prophylactic for, 9
B
V and infectious morbidity after, 4–
5
i
nfections postoperative, 8
p
rophylactic antibiotics for, 3–5
v
agina
l
, 3
abdo
min
al
v.
,
4
i
n
f
ectious mor
b
i
d
it
y
an
d
, 8
v
a
g
ina
l
cu
ff
ce
ll
u
l
itis a
f
ter, 4–
5
Hy
steroscopic sterilization, 106
Hy
steroscopic sur
g
er
y
clinical practice of, key points for, 104
complications i
n
adh
esion
f
ormation as, 10
3
bl
ee
d
ing as, 102–10
3
d
i
l
ation an
d
, 99
d
istension me
d
ia as, 99–10
2
m
ana
g
ement o
f
, 94–104
p
erforation and, 9
9
p
revention of, 94–104
scale of problem and, 94, 95t
electrosurgery and, 97
en
d
ometria
l
preparation in, 96
g
enera
l
princip
l
es o
f
sa
fe
c
ase se
l
ection as, a
pp
ro
p
riate, 9
5
eq
ui
p
ment,
p
ro
p
er as, 96–9
8
l
earnin
g
phase in, awareness of and,
98
p
at
i
ent preparat
i
on as, 96
iatrogenic, fl
uid overload, 97, 97t
o
perating t
h
eaters per
f
orming, 100–101
Ico
d
extrin, 5
7
I
CS
I.
S
e
e
Intrac
y
stop
l
asmic sperm in
j
ectio
n
Indi
g
o carmine, 79
https://t.me/med1917
In
d
e
x
I
n
fect
i
o
n
s
defi
nition, 1
t
ermino
l
ogy an
d
, 1, 2
t
f
o
ll
owin
g
gy
neco
l
o
g
ica
l
sur
g
er
y
anti
b
iotics
f
or
,
c
h
oice o
f,
5
,
6
t
p
at
h
o
g
enesis o
f
, 1–
3
p
revention of, 1–
9
h
y
sterectom
y
, postoperative, 8
pelvic
h
ysterectomy and, 3
T
OP an
d
prevention o
f
, 7
r
a
d
ica
l
cancer surgery comp
l
ications an
d
,
T
OP-associate
d
,
p
revention o
f
, 7–
8
woun
d
hy
sterectom
y
, abdominal and, 4
l
aparoscopic surgery, access methods
a
nd
,
25
I
nfectious morbidity
B
V and post-hysterectomy, 4–
5
h
ysterectomy, vagina
l
an
d
,
8
I
ntercee
d
, 58–59, 58
f
I
nter
g
e
l
a
dh
esion
p
revention, 53–59, 58
f
Interceed v.
,
58–59
,
58f
laparoscop
y
studies for, 54–57
laparotom
y
studies for, 53–5
4
mAFS score for
,
54
,
55f–56f
pelvic pain, 5
7
I
ntestinal injuries, laparoscopic surgery,
6
8–69
I
ntrac
y
stop
l
asmic sperm in
j
ection (ICSI),
2
7
I
ntrauterine
bl
ee
d
in
g
,
hy
steroscopic
sur
g
er
y
,
102
–
103
I
ntrauterine pre
g
nanc
y
, 110–11
1
I
ntravenous p
y
elo
g
ram (IVP), urinar
y
tract
i
n
j
ur
y
postoperative diagnosis of, 80–81
preoperat
i
ve, 77–7
9
I
n vitro
f
erti
l
ization
(
IVF
)
, 12
7
I
n vitro maturation
(
IVM
)
, 12
7
Ische
mi
a.
Se
e
M
y
ocar
d
ia
l
isc
h
emia
IVF
.
S
e
e
In vitro fertilization
IVM
. Se
e
In vitro maturation
IVP.
S
ee Intravenous pyelogram, urinary
tract injury
L
aparoscop
i
c surgery, 67–71.
S
ee a
l
s
o
specifi
c
access
methods
a
bd
omina
l
wa
ll
p
er
f
oration an
d
, 2
9
anest
h
esia com
pl
ications in, 25–26
benefi
ts, 20
blind/closed
,
22
b
owe
l
injury an
d
, 21–22, 68–69, 68t, 71
a
ccess met
h
o
d
s, 23–24
c
h
o
l
ec
y
stectom
y
, 2
1
c
l
ose
d
, 22, 2
8
op
en v
.
,
23–2
6
com
p
lications, 67
e
ndometriosis and
,
34–41
l
aparotomy and, 26
m
inimizing risk of, 26–2
7
counseling, 28–29
d
iagnostic, 21
e
n
do
m
et
ri
os
i
s
a
u
d
it
f
or, 3
8
a
u
d
it resu
l
ts
f
or, 38–41, 39
f
, 39t, 41
t
c
om
p
lications of, 34–4
1
dissection for
,
36–37
,
37f
innovation in
,
41
p
atient counseling for, 3
6
rectal involvement/resection and, 4
0
surgical risks of, 40, 41b
surgica
l
tec
h
niques, 36–38
team approac
h
to, 37–3
8
entr
y
tec
h
niques, 21–22
c
onsensus o
f,
20–29
gy
necolo
g
ical cancer, 17
Hasson-st
y
le, 23–26
h
ospital readmissions, 26
h
ybrid visual/closed, 22
i
n
j
ur
i
es, 67–6
8
a
ccess-re
l
ate
d
, 21, 23–24
classifi
cation of, 21–22
e
ntr
y
-related, 21–2
2
m
anagement of, 69–7
1
p
revention of, 69–7
1
i
nstruments for
,
use of newer
,
2
7
Intergel and studies with, 54–5
7
i
ntestinal injury and, 21–22, 68–69
l
aparotomy an
d
conversion
/
c
omp
l
ications o
f
, 2
6
l
aparotom
y
v
.
,
20
l
iti
g
ation, 2
6
o
p
en,
22
,
28
c
losed
v
.
,
23–2
6
pneumoperitoneum complications and,
2
5
r
ecommen
d
ations
f
or, 28
risk factors, identifi
cation of, 26–27
s
teri
l
ization t
h
rou
gh
, 11
7
t
rocar, 23–2
6
t
u
b
a
l
steri
l
ization
,
20
u
reteric in
j
ur
y
and, 7
1
https://t.me/med1917
In
d
ex 1
39
u
rinary injury an
d
, access met
h
o
d
s, 24
u
rinary tract injury an
d
, 69
vascu
l
ar injury an
d
, 21, 67–68, 7
1
access met
h
o
d
s, 24
Verres nee
dl
e
,
23–26
op
tica
l
, 27
visceral in
j
ur
y
and, 21
visual/o
p
en, 2
2
L
aparoscopic tubal occlusion, 10
6
L
aparotom
y
comp
l
ications, 34
Interge
l
an
d
stu
d
ies wit
h
, 53–54
l
aparoscopic sur
g
er
y
conversion
/
c
omp
l
ications requirin
g
, 26
laparoscopic sur
g
er
y
v
.
,
20
s
terilization throu
g
h, 11
7
L
eiomyomas.
S
ee Submucous leiomyoma
s
L
itigation
laparoscopic surgery, 26
s
terilization failure, 113–11
4
u
r
i
nary tract
i
n
j
ury, 75
L
ow-mo
l
ecu
l
ar-weig
h
t
h
eparin, 14
Ly
mp
h
a
d
enectom
y
, en
d
ometria
l
cancer,
7
M
M
AS
.
S
e
e
Minimal-access sur
g
er
y
M
axon.
S
e
e
Polyglyconat
e
M
etabolic equivalent levels (METs), 87–88
M
ethylene blue, 7
9
Met
r
o
ni
da
z
ole
BV
, 5
i
n
f
ection, 13
T
OP
,
7
M
E
T
s.
S
ee Meta
b
o
l
ic e
q
uiva
l
ent
l
eve
ls
M
inimal-access sur
g
er
y
(MAS), 94
M
iso
p
rostol, 9
9
Modifi
ed AFS (mAFS) score, 54, 55f–56f
M
ultiple pregnancies, 129
r
is
k
o
f
, minimizing, 132–13
3
M
yocar
d
ia
l
isc
h
emia, 89–90
N
Novafi
l.
S
e
e
Pol
y
butester
O
O
H
SS
.
S
ee Ovarian hyperstimulation
syndrome
Oocyte retrieval, 130
Operator error, steri
l
ization
f
ai
l
ure an
d
,
Optica
l
trocars,
l
aparoscopic sur
g
er
y
, 27
Ora
l
contrace
p
tive
p
i
ll
, 16
O
var
i
an cancer
o
varian stimulation and risk of, 130
s
urgery, 1
1
Ovarian
h
yperstimu
l
ation syn
d
rome
OHSS
)
, 127–12
9
p
revention, 128–12
9
r
isk factors for develo
p
ment of, 128
r
isk of, decreasin
g
, 13
2
O
varian stimulation, complications
a
ssociated with
,
127–130
cancer risks as, 130
multiple pregnancies as, 12
9
OHSS as, 127–12
9
P
PAS. See Posta
b
orta
l
se
p
si
s
Patients.
S
ee also Hi
g
h-risk
gy
necolo
gy
p
atient
communication with
,
6
3
s
terilization failure and selection of
,
11
5
P
DS. Se
e
Po
l
y
d
ioxanone
P
e
l
vis, in
f
ection
s
hy
sterectom
y
an
d
,
3
TOP an
d
p
revention o
f
,
7
P
erforation
h
y
steroscop
y
, 99
laparoscopic surgery and abdominal wall,
29
P
eritoneum, abdominal wall closure and
c
losing, 45–46
P
neumoper
i
toneum, 22
l
aparoscopy, comp
l
ications re
l
ate
d
to, 25
Polybutester (Novafi
l), 4
8
Pol
y
dioxanone (PDS), 47
Pol
yg
lactin, 4
8
Polyglyconate (Maxon), 47
Polypropylene
abdominal wound failure, acute and, 48
f
ascia closure, 4
7
Pomeroy met
h
o
d
o
f
steri
l
ization at cesarean
sect
i
on, 117
Posta
b
orta
l
se
p
sis (PAS), 7
P
re
g
nanc
y
.
S
ee a
l
s
o
Mu
l
tip
l
e pre
g
nancies;
Termination of pre
g
nanc
y
ecto
p
ic, sterilization failure and
subsequent, 110–11
1
factors identifi
ed to alter cumulative
probability of, after sterilization, 11
0
i
ntrauterine, steri
l
ization
f
ai
l
ure an
d
su
b
sequent, 110–11
1
s
teri
l
ization an
d
ris
k
o
f
, 10
8
Preimp
l
antation
g
enetic
d
ia
g
nosis, 12
7
Preventa
bl
e
h
arm
,
6
1
https://t.me/med1917
4
0
In
d
e
x
R
Ra
d
ica
l
cancer surgery, 1
1
com
pl
ications o
f
, 12
f
anest
h
etic, 12–1
3
h
emorr
h
a
g
e as, 1
4
i
n
f
ection as
,
1
3
o
r
g
an dama
g
e, 14–1
5
p
erio
p
erative, 12–1
3
p
sychological, 15–1
6
r
educing, 16–18
th
rom
b
osis as, 13–14
t
rans
f
usion, 1
4
outcome o
f
, 1
2
Ra
d
ica
l
vu
l
va
l
sur
g
er
y
, 1
5
Rectum, endometriosis laparoscop
y
and
involvement/resection of
,
40
Ringer’s solution, lactated, 54
mAFS score for
,
54
,
55f–56f
Risk management, 61, 66
Root cause analysis, 6
1
a
d
verse event, 64–6
5
bl
ame an
d
, 6
5
p
reo
p
erative care, 62
S
Saline
,
100
Versapoint operation in, 100, 101f, 102
f
Sexual dysfunction, gynecological cancer
surgery and, 1
6
Skin closure, abdominal wound closure
a
n
d
, 48
Sor
b
ito
l
, 9
7
d
istension me
d
ia, 100
S
p
erm retrieva
l
, 13
1
Step Ra
d
ia
l
Expan
d
in
g
S
y
stem,
l
aparoscopic
sur
g
er
y
,
2
7
S
terilization.
S
ee als
o
Filshie cli
p
sterilization; Hysteroscopic
sterilization
f
o
ll
ow-up, 120–12
1
h
ysteroscopic, 106
menstrua
l
c
y
c
l
e an
d
re
l
ation o
f
, 116
Pomero
y
met
h
o
d
o
f
, at cesarean section,
7
p
ost
p
artum, 11
6
–117
prepregnancy testing and, 116
preprocedure contraception and,
1
6
t
echniques, 106, 107
t
l
aparoscopy, 11
7
l
aparotomy, 11
7
t
imin
g
o
f
operation, 116–117
t
u
b
a
l
,
l
a
p
arosco
p
ic, 2
0
S
terilization failur
e
Cana
d
ian
d
ata set examining, 107–108,
08t, 11
0
ectopic pregnancy a
f
ter, 110–11
1
evi
d
ence o
f
, 115, 115
t
assess
i
n
g
, 114–115
i
dentif
y
in
g
, 114–115
factors infl
uencing, 110
F
ilshie clip method and, 108, 109t
i
ntrauterine pregnancy after, 110–11
1
mechanism of, 111t, 113–11
4
medicolegal consequences of, 113–114
n
eg
l
igence an
d
, 113–11
4
n
onneg
l
igence an
d
, 113–114
o
erator error an
, 11
operator experience/trainin
g
an
d
, 12
0
p
atient selection and, 11
5
r
ates
,
10
7–
109
r
isk, minimizing, 106–121
Submucous leiomyomas, 95, 95
t
Systemic infl
ammatory responses, 1, 2t
T
a
m
o
xi
fe
n
gy
neco
l
o
g
ica
l
cancer an
d
, 16
th
rom
b
osis an
d,
1
3
Termination of pre
g
nanc
y
(TOP),
1
antibiotics, proph
y
lactic for, 8–9
i
nfection associated with, prevention of,
7
–8
pe
l
vic in
f
ection prevention an
d
, 7
T
h
r
o
m
bos
i
s
gy
neco
l
o
g
ica
l
cancer an
d
, 1
3
r
a
d
ica
l
cancer sur
g
er
y
comp
l
ications an
d
,
–
1
4
Tinidazole
,
5
T
OP.
S
ee Termination of pre
g
nanc
y
Transfusion, radical cancer surger
y
c
omplications and, 1
4
Trocar laparoscopy access, 26
abdominal wall, hernia at site of, 25
b
owe
l
injuries an
d
, 23–2
4
h
ematoma an
d
, 24–25
morta
l
it
y
, 2
3
s
a
f
et
y
, 23
u
rinar
y
in
j
uries and, 24
vascular injuries and, 24
woun
d
in
f
ection, 25
Tr
oca
r
s.
Se
e
B
l
unt-tip trocars; Optica
l
t
r
oca
r
s
Tu
b
a
l
occ
l
usion
coa
g
ulation-based, 11
2
follow-up for uncertaint
y
in, 120–121
https://t.me/med1917
In
d
ex 14
1
l
aparoscopic, 106
mec
h
anica
l
, 112
Tu
b
a
l
steri
l
ization,
l
aparoscopic, 20
Tu
b
a
l
sur
g
ica
l
excision, 106
U
U
reteric in
j
uries, 75
i
atro
g
enic, 75
laparoscopic surgery, 7
1
locations
,
77f
t
reatment, 8
1
U
ret
h
ra
l
injury, 7
5
t
reatment, 8
1
U
rinar
y
in
j
uries,
l
aparoscopic sur
g
er
y
a
ccess methods and
,
24
U
rinar
y
tract, 75–82
U
rinary tract injuries
causes
,
7
6
d
etecting, 79–80
d
ocumentation, 8
2
i
ntraoperative
d
iagnosis o
f
, 79–8
0
l
aparoscopic surgery, 6
9
l
itigation an
d
, 75
postoperative
d
ia
g
nosis o
f
, 80–81
p
revention, 76–79
r
isk factors
,
76
s
ites
,
7
6
t
reatment
,
81
t
ypes, 7
6
U
S CREST study, 107–108, 110
V
Va
gi
na.
S
ee a
l
s
o
Bacteria
l
va
g
inosi
s
b
acteria in
,
1
hy
sterectom
y
, 3–5,
8
Va
g
inal cuff cellulitis, BV and post-
hy
sterectom
y
, 4–
5
Vascular endothelial growth factor (VEGF),
2
8
Vascu
l
ar injuries
l
aparoscopic surgery, 21, 67–68, 71
access met
h
o
d
s an
d
, 24
r
a
d
ica
l
gy
neco
l
o
g
ica
l
sur
g
er
y
, 14–15
VE
G
F.
S
e
e
Vascular endothelial
g
rowth
f
actor
Verres needle laparoscopy access, 23–26, 7
0
bowel injuries and, 23–2
4
hematoma and
,
24–25
mortality, 2
3
optica
l
, 2
7
s
a
f
ety, 23
u
rinar
y
in
j
uries an
d
, 24
vascu
l
ar in
j
uries an
d
, 24
wound infection
,
25
Versa
p
oint, 100, 101f, 102
f
Videoconferencing, gynecological oncology
and
,
18
Visceral injuries, laparoscopic surgery, 21
W
Woun
d(
s
)
classifi
cation, 43, 44t
i
n
f
ection
s
hy
sterectom
y
, abdominal and, 4
l
aparoscopic sur
g
er
y
, access methods
a
nd
,
25
Wound closure.
S
ee Abdominal wound
closu
r
e
W
ou
n
d
fa
i
lu
r
e
a
bd
omina
l
, 43–4
4
l
ate, mana
g
ement o
f
, 49
mana
g
ement o
f
, 48–49
defi
nition, 43–44
i
ncidence
,
43–4
4
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана